Fischer Lab
Translational research on retinal disorders
Phase I/II clinical gene therapy trial for CNGA3 based achromatopsia
Partner: | RD-CURE Consortium |
Length / Duration / Start: | Since 10/2012 |
Funding Insititution: | Tistou und Charlotte Kerstan Stiftung |
Results: | Ongoing |
Phase II clinical gene therapy trial for choroideremia
Partner: | STZeyetrial, Nuffield Laboratory of Ophthalmology, NightStaRx Ltd. |
Length / Duration / Start: | Since 10/2014 |
Funding Insititution: | Tistou und Charlotte Kerstan Stiftung |
Results: | Ongoing |
Gene therapy for RPGR based retinitis pigmentosa
Partner: | Nuffield Laboratory of Ophthalmology |
Length / Duration / Start: | Since 10/2012 |
Funding Insititution: | UK Medical Research Council |
Results: | Ongoing, patent application submitted |
Immunology of AAV based retinal gene therapy
Partner: | Reinhild Klein, Laboratory for Immunopathology, Eberhard Karls University Tübingen |
Length / Duration / Start: | Since 10/2015 |
Funding Insititution: | Tistou und Charlotte Kerstan Stiftung |
Results: | Ongoing |
In vitro assays for gene therapy development
Partner: | Stefan Liebau, Institute of Neuroanatomy, Eberhard Karls University Tübingen |
Length / Duration / Start: | Since 10/2015 |
Funding Insititution: | IZKF Promotionsstipendium, Stiftung der Deutschen Wirtschaft |
Results: | Ongoing |
Clinical disease progression in XLRP3 patients
Partner: | Robert MacLaren, Nuffield Laboratory of Ophthalmology, University of Oxford; Camiel Boon, Leiden University Medical Center; |
Length / Duration / Start: | Since 10/2015 |
Funding Insititution: | Studienstiftung des Deutschen Volkes |
Results: | Ongoing |
Natural history of disease in choroideremia
Partner: | STZeyetrial, NighStaRx Ltd. |
Length / Duration / Start: | Since 04/2014 |
Funding Insititution: | ProRetina (travel grant), NighStaRx Ltd. |
Results: | Ongoing |
Use of adaptive optics in patients with retinal disorders
Partner: | Eberhart Zrenner |
Length / Duration / Start: | Since 05/2015 |
Funding Insititution: | - |
Results: | Ongoing |
Functional MRI in patients with retinal disorders
Partner: | Georgios A. Keliris, Max Planck Institute for Biological Cybernetics; Thomas Ethofer, Werner Reichardt Centre for Integrative Neuroscience, Tübingen; |
Length / Duration / Start: | Since 05/2015 |
Funding Insititution: | Tistou und Charlotte Kerstan Stiftung |
Results: | Ongoing |
Overcoming innate immunity towards genetic therapies in the eye
Partner: | SPP 2127 „Gene and Cell Based Therapies to Counteract Neuroretinal Degeneration“ |
Length / Duration / Start: | 01/2019 |
Funding Insititution: | DFG |
Results: | Ongoing |
Clinical Research Labs
Core Facilities
Associated Labs